Alerts will be sent to your verified email
Verify EmailLINCOLN
Lincoln Pharma
|
Bharat Parenterals
|
Kwality Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
8.98 % | n/a | n/a |
R&D as a % of Total Sales
|
1.93 % | 0.41 % | n/a |
Financials
|
|||
5 yr Average ROE
|
15.94 % | 12.73 % | 25.87 % |
5yr average Equity Multiplier
|
1.3 | 1.76 | 2.2 |
5yr Average Asset Turnover Ratio
|
0.84 | 0.86 | 1.09 |
5yr Avg Net Profit Margin
|
14.61 % | 8.73 % | 10.7 % |
Price to Book
|
1.59 | 3.17 | 4.42 |
P/E
|
12.99 | 0.0 | 29.28 |
5yr Avg Cash Conversion Cycle
|
24.49 Days | 122.06 Days | 46.51 Days |
Inventory Days
|
42.89 Days | 46.56 Days | 59.9 Days |
Days Receivable
|
90.22 Days | 179.99 Days | 110.56 Days |
Days Payable
|
111.35 Days | 95.97 Days | 112.27 Days |
5yr Average Interest Coverage Ratio
|
58.2 | 22.68 | 15.91 |
5yr Avg ROCE
|
20.48 % | 16.02 % | 34.24 % |
5yr Avg Operating Profit Margin
|
18.48 % | 11.16 % | 20.92 % |
5 yr average Debt to Equity
|
0.0 | 0.26 | 0.52 |
5yr CAGR Net Profit
|
12.65 % | -9.67 % | 23.39 % |
5yr Average Return on Assets
|
12.28 % | 8.0 % | 12.43 % |
Shareholdings
|
|||
Promoter Holding
|
49.78 % | 67.19 % | 54.83 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
5.7 % | -6.65 % | 0.38 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Lincoln Pharma
|
Bharat Parenterals
|
Kwality Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|